This will give either party customers access enzyme expertise and assets, resulting in cost-effective, green processing for API manufacturing.
Honan will lead the company in identifying and executing acquisitions that complement Emmes’ existing strong federal government client base, expand its biopharma portfolio, enhance its technology offerings, and broaden its global reach
Yonghe as the CDMO partner will provide production process development and cGMP manufacturing services for Ablaze
Through the collaboration, Lonza will gain access to Singzyme’s enzymatic conjugation platform enabling the site-specific binding of payloads with peptidic linkers to proteins of interest
It allows users to generate cell lines suitable for clinical development without their own starter cells, vectors or prior experience in the field.
Ours is a story of India’s resilient public health system and of everyone working together as team India to battle the pandemic
Dolomite Bio scientist demonstrating pipetting into the Nadia Go
Cytel has now established entities in Australia, Shanghai, Beijing, and Singapore, and plans to expand into Seoul and Tokyo in the coming years.
The decision is based on the outcome of a prespecified interim analysis of the Phase 3 AMEERA-5 trial
Subscribe To Our Newsletter & Stay Updated
